Article
Are polymorphisms in oestrogen receptors genes associated with lipid levels in response to hormone therapy?
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology - 1 Aug 2012
Smiderle Lisiane, Mattevi Vanessa Suñé, Giovenardi Márcia, Wender Maria Celeste Osório, Hutz Mara Helena, Almeida Silvana
Abstract excerpt
BACKGROUND: Polymorphisms in the oestrogen receptor 1 (ESR1) and oestrogen receptor 2 (ESR2) genes are associated with intermediate or endpoint markers of cardiovascular disease and with the efficacy of postmenopausal hormone therapy (HT). Contradictory findings have been described in the past and the role of these genetics variants remains unclear. METHODS: A cross-sectional study was carried out with 266...
Topics
- Adult
- Aged
- Biomarkers, Pharmacological
- Brazil
- Cardiovascular Diseases
- Cholesterol
- Cholesterol, LDL
- Cross-Sectional Studies
- Estrogen Receptor alpha
- Estrogen Receptor beta
